WCN25-3854 USE OF GRAFALON (R-ATLG) AND THYMOGLOBULIN (R-ATG) AS INDUCTION IN ABO-INCOMPATIBLE TRANSPLANT RECIPIENTS WITH ANTI-HLA SENSITIZATION
ABO-incompatible kidney transplantation involves desensitization protocols and anti-thymoglobulin induction therapy. The combination of ABO-incompatibility and anti-HLA sensitization poses a significant immunological risk in kidney transplantation. This study evaluates the efficacy and safety of two anti-thymocyte globulins, Grafalon (r-ATLG) and Thymoglobulin (r-ATG), in kidney transplants with both ABO and HLA sensitization.
Authors
- Sonia Mehrotra
- Arun Lal Srivastav (ORCID: https://orcid.org/0000-0003-0238-7395)
- Raj Kumar Sharma (ORCID: https://orcid.org/0000-0003-0623-3238)
- Rohit Kapoor (ORCID: https://orcid.org/0000-0002-2909-8246)
- Abhijeet Kumar (ORCID: https://orcid.org/0000-0001-8280-5053)
- Ashish Tiwari
- R.S. Jaiswal
- Rakesh Kapoor
Institutions
- University of Lucknow (IN)
- Sahara Hospital (IN)
- M.V. Hospital and Research Centre (IN)
- Era's Lucknow Medical College and Hospital (IN)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.970
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00